February 2002 Bulletin

In the News

Chair selected for Council on Research and Scientific Affairs

Joshua J. Jacobs, MD, has been named Chairman of the AAOS Council on Research and Scientific Affairs. His appointment becomes effective at the February 15, 2002 meeting of the AAOS Board of Directors. An Active Fellow of the Academy since 1992, Dr. Jacobs is the current chairman of the AAOS Biomedical Engineering Committee. He also serves as chairman of the Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health. He is active in a number of professional organizations, including service on the Board of Directors of the Orthopaedic Research Society and as chairman of Committee FO4 on Medical and Surgical Devices for the American Society for Testing and Materials.

Dr. Jacobs is the Associate Chairman for Academic Programs in the Department of Orthopaedic Surgery at Rush Medical College in Chicago, Ill., where he also holds an appointment as the Inaugural Crown Family Professor of Orthopaedic Surgery and serves as Director of the Section of Biomaterials and Director of the Orthopaedic Residency Program. He is an experienced clinical investigator in his own right, conducting research studies on such topics as the systemic implications of total joint replacement, bone in-growth and bone remodeling in cementless total knee arthroplasty and fixation in total knee replacement.

Clinical trials initiative set

The AAOS Board of Directors has appointed a Clinical Trials Project Team to study the feasibility of establishing a mechanism of the AAOS for conducting independent clinical trials on a contractual basis for either the public or private sectors. A final report with recommendations will be presented at the May 2002 Board of Directors meeting. The Clinical Trials Project Team consists of Mark Swiontkowski, MD, Chair, and Joseph Bernstein, MD, Robert Keller, MD, James Weinstein, MD, and Gordon Guyatt, PhD, consultant. Read the Project Team charges at http://www3.aaos.org/newsupdt/clintrialcharges.htm

Review of AAOS organizational structure, staff to begin

The Academy in 2005 strategic planning initiative has been completed and the results incorporated in a set of organizational principles that will guide the Academy for the next five years. With this work underway at the Board level, the next step is to review the Academy’s organizational structure and functions, the expertise required of its full-time professional staff by 2005, and to identify future issues facing nonprofit professional organizations that may be lurking in the not too distant future. The Board of Directors has selected an outside consulting firm, RSM McGladrey, to conduct this assessment. The firm is expected to report to the Board of Directors at its May 2002 meeting.

2002 Biennial Orthopaedic Physician Census questionnaires in the mail

The 2002 AAOS member survey to update the profile of orthopaedic practice is now in the mail. It has been sent to every member who has not yet submitted an on-line survey. Conducted every two years, the census allows AAOS to gather data that helps tailor programs to members’ needs. The information gathered also enables the Academy to better represent the specialty in Washington, D.C. and in state houses across the country. All practicing orthopaedic surgeons in the U.S. and Canada should fill out and return a census questionnaire.

Zimmer warns of potential breakage problem with hip implants

Based on information provided by Saint-Gobain, a French manufacturer of ceramic femoral heads, Zimmer Holdings, Inc. said that it is advising surgeons to notify their patients of possible breakage of the femoral head component from one of Saint-Gobain’s product batches of hip implants. Saint-Gobain has advised Zimmer that this potential for breakage is due to their manufacturing process for that batch. Zimmer had voluntarily recalled the affected Saint-Gobain products in August 2001. According to information obtained from Saint-Gobain, approximately 234 zirconia femoral heads distributed by Zimmer since 1999 have the potential to break over time. Zimmer estimates that fewer than 100 of the 234 units were sold in the United States.

Of the 234 femoral heads identified, only four have failed. Zimmer estimates the affected femoral heads are involved in less than one out of every 1,000 hip replacements done since 1999 where Zimmer products were used. Based on information confirmed on January 24, 2002, however, only one batch received by Zimmer has been identified as having potential for a significant incidence of breakage, and the four breakages that have occurred to date were only from that batch.


Home Previous Page